X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Glenmark Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs GLENMARK PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA GLENMARK PHARMA FULFORD INDIA/
GLENMARK PHARMA
 
P/E (TTM) x 398.8 12.0 3,325.0% View Chart
P/BV x 6.2 3.2 196.2% View Chart
Dividend Yield % 0.1 0.4 22.2%  

Financials

 FULFORD INDIA   GLENMARK PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
GLENMARK PHARMA
Mar-17
FULFORD INDIA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs942993 94.9%   
Low Rs450729 61.7%   
Sales per share (Unadj.) Rs691.4325.5 212.4%  
Earnings per share (Unadj.) Rs11.539.3 29.2%  
Cash flow per share (Unadj.) Rs15.448.7 31.6%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.30.2 123.7%  
Book value per share (Unadj.) Rs380.0159.2 238.7%  
Shares outstanding (eoy) m3.90282.17 1.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.02.6 38.1%   
Avg P/E ratio x60.721.9 277.1%  
P/CF ratio (eoy) x45.317.7 256.1%  
Price / Book Value ratio x1.85.4 33.9%  
Dividend payout %17.45.1 342.8%   
Avg Mkt Cap Rs m2,714242,991 1.1%   
No. of employees `0000.413.0 3.4%   
Total wages/salary Rs m50516,408 3.1%   
Avg. sales/employee Rs Th6,073.07,083.9 85.7%   
Avg. wages/employee Rs Th1,137.41,265.4 89.9%   
Avg. net profit/employee Rs Th100.7855.1 11.8%   
INCOME DATA
Net Sales Rs m2,69691,857 2.9%  
Other income Rs m125374 33.6%   
Total revenues Rs m2,82292,230 3.1%   
Gross profit Rs m-4620,367 -0.2%  
Depreciation Rs m152,644 0.6%   
Interest Rs m102,373 0.4%   
Profit before tax Rs m5415,724 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-810 0.0%   
Tax Rs m103,827 0.3%   
Profit after tax Rs m4511,088 0.4%  
Gross profit margin %-1.722.2 -7.8%  
Effective tax rate %17.724.3 72.6%   
Net profit margin %1.712.1 13.7%  
BALANCE SHEET DATA
Current assets Rs m1,73868,746 2.5%   
Current liabilities Rs m54527,027 2.0%   
Net working cap to sales %44.345.4 97.5%  
Current ratio x3.22.5 125.5%  
Inventory Days Days4885 57.0%  
Debtors Days Days496 4.5%  
Net fixed assets Rs m1224,132 0.0%   
Share capital Rs m39282 13.8%   
"Free" reserves Rs m1,44344,643 3.2%   
Net worth Rs m1,48244,925 3.3%   
Long term debt Rs m045,363 0.0%   
Total assets Rs m2,077117,639 1.8%  
Interest coverage x6.77.6 88.1%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x1.30.8 166.3%   
Return on assets %2.611.4 22.8%  
Return on equity %3.024.7 12.2%  
Return on capital %4.319.1 22.5%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m1756,152 0.0%   
Fx outflow Rs m6738,084 8.3%   
Net fx Rs m-65648,068 -1.4%   
CASH FLOW
From Operations Rs m906,574 1.4%  
From Investments Rs m105-7,124 -1.5%  
From Financial Activity Rs m-145,432 -0.3%  
Net Cashflow Rs m1811,992 9.1%  

Share Holding

Indian Promoters % 0.0 48.3 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 6.9 55.1%  
FIIs % 0.1 34.4 0.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 10.5 201.9%  
Shareholders   4,783 56,727 8.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Metal Stocks Top Losers(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading marginally above the dotted line.

Related Views on News

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS